Oramed to Present at H.C. Wainwright 7th Annual Israel Conference
NEW YORK, November 11, 2021 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that Chief Executive Officer Nadav Kidron will present a company overview at the H.C. Wainwright 7th Annual Israel Virtual Conference, on November 15, 2021 at […]
